ÂÜÀòÂÒÂ×

Ronen Eavri possesses extensive experience in the biopharmaceutical and healthcare sectors. Currently a member of 8400 - The Health Network since January 2020 and serving as CEO and Co-founder of Barcode Nanotech since February 2017, Ronen previously held leading scientific roles at Johnson & Johnson from 2012 to 2017, focusing on preclinical development, product formulation, and patent applications. Prior roles include work as a scientist at D Pharm LTD., conducting research on innovative biopharmaceuticals, and a postdoctoral fellowship at the Massachusetts Institute of Technology, studying mechanisms of learning and memory in the mouse brain. Academic credentials include an MBA from Technion - Israel Institute of Technology and multiple degrees in Biotechnology and Biochemistry from The Hebrew University of Jerusalem.